Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nasopharyngeal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05517135
What this trial is testing

TReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)

Who this might be right for
Nasopharyngeal Carcinoma
National Cancer Centre, Singapore 1,000
Large-scale testing (Phase 3)Looking for participantsNCT05772208
What this trial is testing

Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 459
Large-scale testing (Phase 3)Study completedNCT00201396
What this trial is testing

Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
National Health Research Institutes, Taiwan 480
Not applicableEnrolling By InvitationNCT06763640
What this trial is testing

Prognostic Value of TIL in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Jiangxi Provincial Cancer Hospital 216
Large-scale testing (Phase 3)Active Not RecruitingNCT05304468
What this trial is testing

Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 452
Early research (Phase 1)Study completedNCT02759250
What this trial is testing

ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Cancer
argenx 11
Large-scale testing (Phase 3)Looking for participantsNCT06976190
What this trial is testing

MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinoma
Lepu Biopharma Co., Ltd. 446
Not applicableStudy completedNCT03981224
What this trial is testing

The Value of Post-radiation Detectable Plasma EBV DNA in High-risk Nasopharyngeal Carcinoma Patients

Who this might be right for
Nasopharyngeal Carcinoma
Taichung Veterans General Hospital 706
Testing effectiveness (Phase 2)Study completedNCT00603915
What this trial is testing

Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
University Health Network, Toronto 20
Not applicableUnknownNCT02063399
What this trial is testing

Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis

Who this might be right for
Nasopharyngeal Carcinoma
Chinese University of Hong Kong 20,302
Testing effectiveness (Phase 2)Looking for participantsNCT06019130
What this trial is testing

Nivolumab in Children and Adults With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal CancerNasopharyngeal Neoplasms+1 more
German Society for Pediatric Oncology and Hematology GPOH gGmbH 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789158
What this trial is testing

Induction Chemotherapy Response-Guided Reduced-Dose Radiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Fudan University 269
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07388758
What this trial is testing

Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 37
Not applicableStudy completedNCT00898664
What this trial is testing

DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 74
Not applicableStudy completedNCT00021138
What this trial is testing

Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking

Who this might be right for
Esophageal CancerHead and Neck CancerLung Cancer
Personal Improvement Computer Systems
Not applicableEnded earlyNCT02388932
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma+25 more
Case Comprehensive Cancer Center 3
Early research (Phase 1)Looking for participantsNCT06886347
What this trial is testing

Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Metastatic Nasopharyngeal Carcinoma
Chen Xiaozhong 47
Early research (Phase 1)UnknownNCT06232863
What this trial is testing

BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer

Who this might be right for
Solid Tumor, Adult
Zhuhai Beihai Biotech Co., Ltd 24
Not applicableStudy completedNCT01015963
What this trial is testing

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 69
Large-scale testing (Phase 3)Active Not RecruitingNCT03306121
What this trial is testing

TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 322
Next Page